Back
Ligand Pharmaceuticals, Inc. Vs. Ziff Davis, Inc. Industry Stock Comparison
Sell
47
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$200.02
Seasonality Move:
4.34%
Sell
39
ZD
Ziff Davis, Inc.
Last Price:
$43.22
Seasonality Move:
6.2%
Sell
47
Ligand Pharmaceuticals, Inc. (LGND)
is a Sell
Is Ligand Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Ligand Pharmaceuticals, Inc. [LGND] share price is $199.93. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ziff Davis, Inc. (ZD)
is a Sell
Is Ziff Davis, Inc. a Buy, Sell or Hold?
-
The current Ziff Davis, Inc. [ZD] share price is $43.19. The Score for ZD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals, Inc.'s stock price today?
-
The Ligand Pharmaceuticals, Inc. share price today is $199.93The current trend is relatively stagnant and LGND is experiencing slight buying pressure.
ZD Stock Price Chart
What is Ziff Davis, Inc.'s stock price today?
-
The Ziff Davis, Inc. share price today is $43.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZD is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 48.61 | Sell |
| Chaikin Money Flow: | 97615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (198.65 - 210.81) | Sell |
| Bollinger Bands (100): | (189.54 - 205.56) | Buy |
ZD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 62.6 | Buy |
| Chaikin Money Flow: | 511387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.75 - 44.97) | Buy |
| Bollinger Bands (100): | (31.29 - 40.27) | Buy |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 199.64 | Buy |
| 20-day SMA: | 204.92 | Sell |
| 50-day SMA: | 198.1 | Buy |
| 200-day SMA: | 176.56 | Buy |
| 8-day EMA: | 200.07 | Sell |
| 20-day EMA: | 201.52 | Sell |
| 50-day EMA: | 199.39 | Buy |
| 200-day EMA: | 177.22 | Buy |
ZD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.69 | Buy |
| 20-day SMA: | 41.91 | Buy |
| 50-day SMA: | 37.19 | Buy |
| 200-day SMA: | 35.41 | Buy |
| 8-day EMA: | 42.46 | Buy |
| 20-day EMA: | 41.13 | Buy |
| 50-day EMA: | 38.51 | Buy |
| 200-day EMA: | 37.17 | Buy |
Ligand Pharmaceuticals, Inc. Earnings Growth & LGND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.27 per share.
Ziff Davis, Inc. Earnings Growth & ZD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.50 per share, an increase this year of $0.19 per share, and an increase next year of $0.48 per share.
Ligand Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ziff Davis, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||